Indivior
Indivior Inc.
10710 Midlothian Turnpike, Suite 430
Richmond, VA 23235
Phone: (804) 379-1090Website: http://indivior.com/Careers: indivior.com/careers
Latest news
- FDA Approves Opvee (nalmefene hydrochloride) Prescription Nasal Spray to Reverse Opioid Overdose
22 May 2023 - Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
19 January 2023 - Opiant Pharmaceuticals Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose
22 November 2022 - FDA Approves Perseris (risperidone) for Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
27 July 2018
Drugs Associated with Indivior Inc.
Indivior Inc. manufactures, markets and/or distributes more than 4 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Opvee
Generic name: nalmefene Drug class: antidotes |
||
|
Perseris
Generic name: risperidone Drug class: atypical antipsychotics |
||
|
Sublocade
Generic name: buprenorphine |
271 reviews | 8.0 / 10 |
|
Suboxone
Generic name: buprenorphine/naloxone Drug class: narcotic analgesic combinations |
650 reviews | 8.6 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||